article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

For the first time, companies across the global healthcare sector, including AstraZeneca , GSK, Novo Nordisk and Roche, have united to discuss with energy providers in China and India, about scaling renewable power across their supply chains. This step is important as these countries are key markets for pharmaceuticals manufacturing.

article thumbnail

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Pharmaceutical Technology

The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs. Fosun Pharma chairman Wu Yifang stated: “We are glad to be supported by IFC to localise pharmaceutical manufacturing and distribution in Africa.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

America’s healthcare costs are in deep crisis

World of DTC Marketing

SUMMARY: The media loves to blame pharma companies for high healthcare costs, but unless we start to invest in healthy lifestyles, we’re headed for a healthcare crisis the likes of which we have never experienced. This means higher healthcare costs. Forget the fact that prescription drugs only account for $.10

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

Can we get healthcare right?

World of DTC Marketing

The poll from the Kaiser Family Foundation finds that 83 percent of the public favors allowing the government to negotiate lower drug prices, for people both on Medicare and those in private insurance plans” Pharma, however, is fighting back. The post Can we get healthcare right? Innovation and Competition Act.

article thumbnail

The continued shame of pharma

World of DTC Marketing

Still, the pharma industry is fighting hard to keep it off the table. Currently, federal law prohibits Medicare from negotiating drug prices directly with manufacturers. Pharma is a very profitable industry. The pharma industry has been a solid place to invest money over time. The secretary of the U.S.

Pharma 256
article thumbnail

FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too

Fierce Pharma

FDA chided Kilitch Healthcare India for “poor practices” tied to written procedures around microbial contamination, shoddy lab records, behaviors that could have caused contamination and quality control lapses. In a four-observation warning letter issued this week, the U.S.

FDA 248